PhysIQ announced today that it appointed the Scripps Research Translational Institute digital medicine director as its chief medical officer.

Dr. Steve Steinhubl will remain with SRTI, where he’s been the director of digital medicine for more than seven years, while he takes on his new role at PhysIQ as he looks to help advance the company’s AI-based analytics platform for improving clinical outcomes and lowering costs, according to a news release.

“Over the last 5 years I’ve been fortunate enough to collaborate with the PhysIQ team on a number of projects,” Steinhubl said in the release. “Their unwavering commitment to evidence-driven research is unparalleled. PhysIQ’s vision and drive for using cutting-edge digital technologies to enable more precise and individualized healthcare makes me extremely proud to be joining their amazing team.

“I look forward to helping expand upon fundamental research into early detection of medical conditions that would help drive better outcomes.”

In his new role at PhysIQ, Steinhubl is slated to drive the deployment of the company’s AI platform to health systems and provider groups around the world. The company’s former CMO, Dr. Stephen Ondra, will continue as a senior advisor to the company.

Before joining PhysIQ and prior to his time at SRTI, Steinhubl served as the director of cardiovascular wellness and the medical director for employee wellness for the Geisinger Healthcare System. He also served as chief cardiology fellow at the Cleveland Clinic.

“As we continue an incredible growth and innovation period for physIQ, Steve will help us lead adoption and expansion of our solutions for healthcare delivery and digitally enabled clinical trials,” PhysIQ CEO Gary Conkright said. “He is a recognized thought leader and researcher of digital medicine solutions, their adoption and the value they provide. Steve has been a long-time advisor and friend of physIQ, and we are honored to have him onboard as we strengthen our leadership position in the industry.”